These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 631973)

  • 1. Criteria for the evaluation of cytostatic chemotherapy.
    Dold U
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):68-71. PubMed ID: 631973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot studies and new agent programs of the Eastern Cooperative Oncology Group.
    Bennett JM; Zelen M
    Cancer Treat Rep; 1980; 64(2-3):525-32. PubMed ID: 7407794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II clinical trial of anticancer drugs].
    Izumi T; Kurihara M
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1493-8. PubMed ID: 1854220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internation workshop on surgical adjuvant antineoplastic chemotherapy in solid tumors. Conclusions and recommendations of the workshop. Clinical and biological background of surgical adjuvant chemotherapy.
    Perevodchikova N; Bonadonna G
    Arch Geschwulstforsch; 1978; 48(7):602-4. PubMed ID: 736738
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ways to overcome the contradictions between the experimental and clinical chemotherapy of tumors].
    Syrkin AB
    Vopr Onkol; 1990; 36(6):740-4. PubMed ID: 2378096
    [No Abstract]   [Full Text] [Related]  

  • 6. Criticism of tumor response criteria raises trial design questions.
    Twombly R
    J Natl Cancer Inst; 2006 Feb; 98(4):232-4. PubMed ID: 16478740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trials in cancer: present status and analysis methods.
    Lee YJ
    Drugs Exp Clin Res; 1986; 12(1-3):57-71. PubMed ID: 3732056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical trials.
    Carter SK; Selawry O; Slavik M
    Natl Cancer Inst Monogr; 1977 Mar; (45):75-80. PubMed ID: 927497
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.
    Gwede CK; Johnson DJ; Daniels SS; Trotti A
    J Oncol Manag; 2002; 11(2):15-21. PubMed ID: 11989815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designs for group sequential phase II clinical trials.
    Chang MN; Therneau TM; Wieand HS; Cha SS
    Biometrics; 1987 Dec; 43(4):865-74. PubMed ID: 3427171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of Cooperative Group evaluation criteria for multiple-drug therapy for breast cancer.
    Davis HL; Multhauf P; Klotz J
    Cancer Treat Rep; 1980; 64(2-3):507-17. PubMed ID: 7407792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase II therapeutic trials in Cancerology: what's new? For a better multicenter and multidisciplinary cooperation].
    Pignon JP
    Gastroenterol Clin Biol; 1992; 16(2):131-3. PubMed ID: 1568539
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and analysis of non-inferiority mortality trials in oncology.
    Carroll K; Milsted B; Lewis JA
    Stat Med; 2004 Sep; 23(17):2771-4; author reply 2774-8. PubMed ID: 15316946
    [No Abstract]   [Full Text] [Related]  

  • 16. [The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria].
    Isaka S; Fuse H; Akaza H; Moriyama N; Usami M; Kotake T; Matsumura Y; Imai K; Yamanaka H; Matsumoto K
    Hinyokika Kiyo; 1987 Sep; 33(9):1389-95. PubMed ID: 3434494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid in vitro labeling index method for predicting response of human solid tumors to chemotherapy.
    Thirlwell MP; Livingston RB; Murphy WK; Hart JS
    Cancer Res; 1976 Sep; 36(9 pt.1):3279-83. PubMed ID: 975089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytostatic chemotherapy and sensitivity tests (oncobiograms) (author's transl)].
    Matthias M; Matthes T; Tanneberger S
    Z Erkr Atmungsorgane; 1975 Feb; 142(2):132-9. PubMed ID: 1226879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Criteria for the determination of the efficacy of solid cancer chemotherapy].
    Saito T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):626-34. PubMed ID: 3954385
    [No Abstract]   [Full Text] [Related]  

  • 20. [Developments and problems of cytostatic chemotherapy].
    Gross R
    Internist (Berl); 1971; 12():Suppl 1:109-15. PubMed ID: 4944099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.